Peroxisome proliferator-activated receptor γ induces growth arrest and differentiation markers of human colon cancer cells

被引:249
作者
Kitamura, S [1 ]
Miyazaki, Y [1 ]
Shinomura, K [1 ]
Kondo, S [1 ]
Kanayama, S [1 ]
Matsuzawa, Y [1 ]
机构
[1] Osaka Univ, Sch Med, Dept Internal Med 2, Osaka 5650871, Japan
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1999年 / 90卷 / 01期
关键词
PPAR gamma; colon cancer cells; differentiation;
D O I
10.1111/j.1349-7006.1999.tb00668.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Peroxisome proliferator-activated receptor gamma (PPAR gamma), one of the nuclear receptors expressed in adipose tissue, plays an important role in adipocyte differentiation. In this study, we investigated the expression of PPAR gamma and its role in cellular growth and differentiation in six colon cancer cell lines: HT-29, CaCo-2, SW-480, DLD-1, LoVo, and T-84. All sis expressed PPAR gamma mRNA and protein, shown respectively on northern and western blot analyses. Luciferase assay in HT-29 cells, which strongly express PPAR gamma, showed that troglitazone, a selective ligand for PPAR gamma, transactivated the transcription of a peroxisome proliferator response element (PPRE)-driven promoter. Furthermore, troglitazone caused a marked decrease in [H-3]thymidine incorporation and G1 cell-cycle arrest determined by flow cytometry. Finally, troglitazone induced expression of mRNAs for villin and intestinal alkaline phosphatase, markers for enterocyte differentiation. In conclusion, human colon cancer cells express PPAR gamma the ligands of which inhibit cell growth and induce differentiation markers.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 19 条
[1]   PPAR gamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A [J].
Altiok, S ;
Xu, M ;
Spiegelman, BM .
GENES & DEVELOPMENT, 1997, 11 (15) :1987-1998
[2]   Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients [J].
Auboeuf, D ;
Rieusset, J ;
Fajas, L ;
Vallier, P ;
Frering, V ;
Riou, JP ;
Staels, P ;
Auwerx, J ;
Laville, M ;
Vidal, H .
DIABETES, 1997, 46 (08) :1319-1327
[3]   PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-GAMMA - ADIPOSE-PREDOMINANT EXPRESSION AND INDUCTION EARLY IN ADIPOCYTE DIFFERENTIATION [J].
CHAWLA, A ;
SCHWARZ, EJ ;
DIMACULANGAN, DD ;
LAZAR, MA .
ENDOCRINOLOGY, 1994, 135 (02) :798-800
[4]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[5]   The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonic cancers [J].
DuBois, RN ;
Gupta, R ;
Brockman, J ;
Reddy, BS ;
Krakow, SL ;
Lazar, MA .
CARCINOGENESIS, 1998, 19 (01) :49-53
[6]   The organization, promoter analysis, and expression of the human PPAR gamma gene [J].
Fajas, L ;
Auboeuf, D ;
Raspe, E ;
Schoonjans, K ;
Lefebvre, AM ;
Saladin, R ;
Najib, J ;
Laville, M ;
Fruchart, JC ;
Deeb, S ;
VidalPuig, A ;
Flier, J ;
Briggs, MR ;
Staels, B ;
Vidal, H ;
Auwerx, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) :18779-18789
[7]   15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) IS A LIGAND FOR THE ADIPOCYTE DETERMINATION FACTOR PPAR-GAMMA [J].
FORMAN, BM ;
TONTONOZ, P ;
CHEN, J ;
BRUN, RP ;
SPIEGELMAN, BM ;
EVANS, RM .
CELL, 1995, 83 (05) :803-812
[8]   Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma [J].
Kliewer, SA ;
Sundseth, SS ;
Jones, SA ;
Brown, PJ ;
Wisely, GB ;
Koble, CS ;
Devchand, P ;
Wahli, W ;
Willson, TM ;
Lenhard, JM ;
Lehmann, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4318-4323
[9]   A PROSTAGLANDIN J(2) METABOLITE BINDS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA AND PROMOTES ADIPOCYTE DIFFERENTIATION [J].
KLIEWER, SA ;
LENHARD, JM ;
WILLSON, TM ;
PATEL, I ;
MORRIS, DC ;
LEHMANN, JM .
CELL, 1995, 83 (05) :813-819
[10]   Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay [J].
Krey, G ;
Braissant, O ;
LHorset, F ;
Kalkhoven, E ;
Perroud, M ;
Parker, MG ;
Wahli, W .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (06) :779-791